UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 24, 2024
Accession Number:
0001140361-24-003291
Submission Type:
POS AM
CIK:
0001576263
Company Name:
Mirati Therapeutics, Inc.
File Number:
333-191544